SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹133 Cr | ₹128 Cr | ₹95 Cr | ₹8,298,024 Cr | ₹83 Cr |
What is the latest Revenue of SAKAR HEALTHCARE ?
Year | Revenue |
---|---|
Mar2024 | ₹133 Cr |
Mar2023 | ₹128 Cr |
Mar2022 | ₹95 Cr |
Mar2021 | ₹8,298,024 Cr |
Mar2020 | ₹83 Cr |
How is Revenue of SAKAR HEALTHCARE Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹133 Cr | 4.00 | |
Mar2023 | ₹128 Cr | 35.35 | |
Mar2022 | ₹95 Cr | -100.00 | |
Mar2021 | ₹8,298,024 Cr | 9,999,928.87 | |
Mar2020 | ₹83 Cr | - |
Compare Revenue of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹638.2 Cr | -2.2% | -8.4% | -26.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -2.2% |
-8.4% |
-26.9% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses